AbbVie: Strong 2026 Outlook, Expect Dividend Increases
Source: SeekingAlpha
2026-03-27 14:42:21 ET
Shares of AbbVie Inc. ( ABBV ) are down approximately 10% since my October 2025 update, in which I outlined the strong commercial progress and the company’s emerging efforts in the obesity market with the in-licensed amylin analog candidate GUBamy, now called ABBV-295. I was also cautious about the near-term share price performance expectations as the valuation reached 10-year highs, and that is what has essentially happened since then, although worsening market conditions did most of the work....
Read the full article on Seeking Alpha
For further details see:
AbbVie: Strong 2026 Outlook, Expect Dividend Increases
AbbVie Inc.
NASDAQ: ABBV
ABBV Trading
0.88% G/L:
$213.21 Last:
2,596,332 Volume:
$212.26 Open:
ABBV Latest News
March 30, 2026 08:00:00 am
Allergan Aesthetics Releases Findings on the Safety and Efficacy of Repeat TrenibotE Treatments and Data on Medical Weight Loss Aesthetics Patient Behaviors at the 2026 American Academy of Dermatology Meeting (AAD)
March 30, 2026 06:50:00 am
This Top ETF Recently Added a Healthy Dose of These High-Yielding Dividend Stocks
March 27, 2026 10:00:00 am
AbbVie to Highlight New Clinical and Real-World Evidence Advancing Standards of Care in Immune-Mediated Skin Diseases at the 2026 AAD Annual Meeting
March 27, 2026 06:06:00 am
Here's How Many Shares of AbbVie (ABBV) Stock You'd Need for $10,000 in Yearly Dividends
ABBV Stock Data
$396,361,630,803
1,749,710,786
N/A
2503
N/A
Pharmaceuticals
Healthcare
US
North Chicago
